Exchange: NASDAQ·Updated 08:18 AM EDT
RLAY logo

RLAY Relay Therapeutics Inc

$18.77
$0.00
(0.00%)
Pre-Market
Prev Close $18.77
Reported EarningsAug 6
Mkt Cap$4.11B
Vol11,724.00

About RLAY

Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.
39

Bearish Sentiment

How do you feel about RLAY?

Advertisement|Remove ads.